| Type |
Details |
Score |
| GXD Expression |
| Probe: |
MGI:5001783 |
| Assay Type: |
RNA in situ |
| Annotation Date: |
2014-02-07 |
| Strength: |
Absent |
| Sex: |
Female |
| Emaps: |
EMAPS:1796223 |
|
| Stage: |
TS23 |
| Assay Id: |
MGI:5542337 |
| Age: |
embryonic day 15.5 |
| Image: |
GUDMAP:10253 |
|
| Specimen Label: |
GUDMAP:10253 |
| Detected: |
false |
| Specimen Num: |
2 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Fenner MH |
| Year: |
1996 |
| Journal: |
GenBank Submission |
| Title: |
Mus musculus strain Balb/c fas ligand mRNA, complete cds |
|
|
| Pages: |
U58995 |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
mutant stock, targeted mutation |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Rengarajan J |
| Year: |
2000 |
| Journal: |
Immunity |
| Title: |
Sequential involvement of NFAT and Egr transcription factors in FasL regulation. |
| Volume: |
12 |
| Issue: |
3 |
| Pages: |
293-300 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Lavin MF |
| Year: |
2002 |
| Journal: |
Toxicology |
| Title: |
Upregulation of FasL and apoptosis in thymic lymphomas in Atm knock-in mice. |
| Volume: |
181-182 |
|
| Pages: |
483-9 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Zhao H |
| Year: |
2013 |
| Journal: |
Invest Ophthalmol Vis Sci |
| Title: |
Age-dependent changes in FasL (CD95L) modulate macrophage function in a model of age-related macular degeneration. |
| Volume: |
54 |
| Issue: |
8 |
| Pages: |
5321-31 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Allais A |
| Year: |
2010 |
| Journal: |
J Neurochem |
| Title: |
Balanced effect of PACAP and FasL on granule cell death during cerebellar development: a morphological, functional and behavioural characterization. |
| Volume: |
113 |
| Issue: |
2 |
| Pages: |
329-40 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Xiao S |
| Year: |
2001 |
| Journal: |
Eur J Immunol |
| Title: |
Sp1 is the major fasl gene activator in abnormal CD4(-)CD8(-)B220(+) T cells of lpr and gld mice. |
| Volume: |
31 |
| Issue: |
11 |
| Pages: |
3339-48 |
|
•
•
•
•
•
|
| UniProt Feature |
| Begin: |
273 |
| Description: |
In gld; abolishes binding of FASL to its receptor. |
| Type: |
sequence variant |
| End: |
273 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Kiaei M |
| Year: |
2007 |
| Journal: |
Exp Neurol |
| Title: |
Matrix metalloproteinase-9 regulates TNF-alpha and FasL expression in neuronal, glial cells and its absence extends life in a transgenic mouse model of amyotrophic lateral sclerosis. |
| Volume: |
205 |
| Issue: |
1 |
| Pages: |
74-81 |
|
•
•
•
•
•
|
| Allele |
| Name: |
Fas ligand; endonuclease-mediated mutation 1, Shanghai Model Organisms Center |
| Allele Type: |
Endonuclease-mediated |
| Attribute String: |
Humanized sequence, Inserted expressed sequence |
|
•
•
•
•
•
|
| Allele |
| Name: |
Fas ligand; endonuclease-mediated mutation 2, Shanghai Model Organisms Center |
| Allele Type: |
Endonuclease-mediated |
| Attribute String: |
Null/knockout |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Ehrenschwender M |
| Year: |
2009 |
| Journal: |
Adv Exp Med Biol |
| Title: |
The role of FasL and Fas in health and disease. |
| Volume: |
647 |
|
| Pages: |
64-93 |
|
•
•
•
•
•
|
| Protein Coding Gene |
| Type: |
protein_coding_gene |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Chakraborty M |
| Year: |
2001 |
| Journal: |
Cancer Res |
| Title: |
Par-4 drives trafficking and activation of Fas and Fasl to induce prostate cancer cell apoptosis and tumor regression. |
| Volume: |
61 |
| Issue: |
19 |
| Pages: |
7255-63 |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
coisogenic, mutant strain, endonuclease-mediated mutation |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
69
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| GO Term |
|
•
•
•
•
•
|
| GO Term |
|
•
•
•
•
•
|
| Allele |
| Name: |
transgene insertion B, Monique De Paepe |
| Allele Type: |
Transgenic |
| Attribute String: |
Inducible, Inserted expressed sequence |
|
•
•
•
•
•
|
| Allele |
| Name: |
transgene insertion D, Monique De Paepe |
| Allele Type: |
Transgenic |
| Attribute String: |
Inducible, Inserted expressed sequence |
|
•
•
•
•
•
|
| Publication |
| First Author: |
de Paepe ME |
| Year: |
2010 |
| Journal: |
Pediatr Res |
| Title: |
Effects of Fas-ligand overexpression on alveolar type II cell growth kinetics in perinatal murine lungs. |
| Volume: |
68 |
| Issue: |
1 |
| Pages: |
57-62 |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
coisogenic, mutant strain, transgenic |
|
•
•
•
•
•
|
| Publication |
| First Author: |
De Paepe ME |
| Year: |
2008 |
| Journal: |
Am J Pathol |
| Title: |
Fas-ligand-induced apoptosis of respiratory epithelial cells causes disruption of postcanalicular alveolar development. |
| Volume: |
173 |
| Issue: |
1 |
| Pages: |
42-56 |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
333
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
51
 |
| Fragment?: |
true |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Johnstone RW |
| Year: |
1996 |
| Journal: |
Mol Cell Biol |
| Title: |
A novel repressor, par-4, modulates transcription and growth suppression functions of the Wilms' tumor suppressor WT1. |
| Volume: |
16 |
| Issue: |
12 |
| Pages: |
6945-56 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Xie J |
| Year: |
2005 |
| Journal: |
J Biol Chem |
| Title: |
PAR-4 is involved in regulation of beta-secretase cleavage of the Alzheimer amyloid precursor protein. |
| Volume: |
280 |
| Issue: |
14 |
| Pages: |
13824-32 |
|
•
•
•
•
•
|
| Protein Domain |
| Type: |
Family |
| Description: |
Prostate apoptosis response 4 (Par-4) induced apoptosis of selective prostate cancer cells PC-3, DU-145, and TSU-Pr and caused tumor regression by inhibition of NF-kappaB activity and cell membrane trafficking of Fas and FasL that leads to the activation of the Fas-Fas-associated death domain-caspase-8 pro-death pathway []. It modulates transcription and growth suppression functions of the Wilms' tumor suppressor WT1. It down-regulates the anti-apoptotic protein BCL2 via its interaction with WT1 []. Par-4 also regulates the amyloid precursor protein (APP) cleavage activity of BACE1 []. |
|
•
•
•
•
•
|
| Publication |
| First Author: |
De Paepe ME |
| Year: |
2011 |
| Journal: |
Am J Pathol |
| Title: |
Alveolar epithelial cell therapy with human cord blood-derived hematopoietic progenitor cells. |
| Volume: |
178 |
| Issue: |
3 |
| Pages: |
1329-39 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Andera L |
| Year: |
2009 |
| Journal: |
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub |
| Title: |
Signaling activated by the death receptors of the TNFR family. |
| Volume: |
153 |
| Issue: |
3 |
| Pages: |
173-80 |
|
•
•
•
•
•
|
| Protein Domain |
| Type: |
Domain |
| Description: |
This entry represents the death domain (DD) found in the FS7-associated cell surface antigen (FAS). FAS, also known as TNFRSF6 (TNF receptor superfamily member 6), APT1, CD95, FAS1, or APO-1, together with FADD (Fas-associating via Death Domain) and caspase 8, is an integral part of the death inducing signalling complex (DISC), which plays an important role in the induction of apoptosis and is activated by binding of the ligand FasL to FAS [, ]. FAS also plays a critical role in self-tolerance by eliminating cell types (autoreactive T and B cells) that contribute to autoimmunity [].DDs are protein-protein interaction domains found in a variety of domain architectures. Their common feature is that they form homodimers by self-association or heterodimers by associating with other members of the DD superfamily including CARD (Caspase activation and recruitment domain), DED (Death Effector Domain), and PYRIN. They serve as adaptors in signaling pathways and can recruit other proteins into signaling complexes [, ]. |
|
•
•
•
•
•
|
| Protein Domain |
| Type: |
Family |
| Description: |
Like all apoptotic cell death, T cell receptor (TCR)-mediated death can bedivided into two phases: an inductive phase and an effector phase. The effector phase includes a sequence of steps that are common to apoptosis inmany cell types, which, if not interrupted, will lead to cell death. Theinduction phase, which often requires the expression of new genes, consistsof a set of signals that activate the effector phase. Outside the thymus,most, if not all, of the TCR-mediated apoptosis of mature T cells (sometimesreferred to as activation-induced cell death (AICD)) is induced through thesurface antigen Fas pathway: activation through the TCR induces expressionof the Fas (CD95) ligand (FasL); the expression of FasL on either aneighbouring cell, or on the Fas-bearing cell, induces trimerisation of Fas,which then initiates a signal-transduction cascade, leading to apoptosis of the Fas-bearing cell. This commitment stage requires the activation of keydeath-inducing enzymes, termed caspases, which act by cleaving proteins that are essential for cell survival and proliferation[, ].Fas is also known to be essential in the death of hyperactivated peripheralCD4+ cells: in the absence of Fas, mature peripheral T cells do not die, butthe activated cells continue to proliferate, producing cytokines that leadto grossly enlarged lymph nodes and spleen. Fas belongs to the tumournecrosis factor receptor (TNFR) family of cysteine-rich type I membranereceptors; its ligand (FasL) is expressed on activated lymphocytes, NK cells,platelets, certain immune-privileged cells and some tumour cells [, ].Defects in the Fas-FasL system are associated with various disease syndromes.Mice with non-functional Fas or FasL display characteristics of lympho-proliferative disorder, such as lymphadenopathy, splenomegaly, and elevated secretion of IgM and IgG. These mice also secrete anti-DNA autoantibodiesand rheumatoid factor []. |
|
•
•
•
•
•
|
| Protein Coding Gene |
| Type: |
protein_coding_gene |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| GO Term |
|
•
•
•
•
•
|
| GO Term |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Chervonsky AV |
| Year: |
1997 |
| Journal: |
Cell |
| Title: |
The role of Fas in autoimmune diabetes. |
| Volume: |
89 |
| Issue: |
1 |
| Pages: |
17-24 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Bajou K |
| Year: |
2008 |
| Journal: |
Cancer Cell |
| Title: |
Plasminogen activator inhibitor-1 protects endothelial cells from FasL-mediated apoptosis. |
| Volume: |
14 |
| Issue: |
4 |
| Pages: |
324-34 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Hattori K |
| Year: |
1997 |
| Journal: |
Blood |
| Title: |
A metalloproteinase inhibitor prevents lethal acute graft-versus-host disease in mice. |
| Volume: |
90 |
| Issue: |
2 |
| Pages: |
542-8 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Doma E |
| Year: |
2010 |
| Journal: |
FEBS Lett |
| Title: |
A novel role of microtubular cytoskeleton in the dynamics of caspase-dependent Fas/CD95 death receptor complexes during apoptosis. |
| Volume: |
584 |
| Issue: |
5 |
| Pages: |
1033-40 |
|
•
•
•
•
•
|
| Protein Coding Gene |
| Type: |
protein_coding_gene |
| Organism: |
Mus caroli |
|
•
•
•
•
•
|
| Protein Coding Gene |
| Type: |
protein_coding_gene |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Protein Coding Gene |
| Type: |
protein_coding_gene |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Protein Coding Gene |
| Type: |
protein_coding_gene |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Protein Coding Gene |
| Type: |
protein_coding_gene |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Protein Coding Gene |
| Type: |
protein_coding_gene |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Protein Coding Gene |
| Type: |
protein_coding_gene |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Protein Coding Gene |
| Type: |
protein_coding_gene |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Protein Coding Gene |
| Type: |
protein_coding_gene |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Protein Coding Gene |
| Type: |
protein_coding_gene |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Protein Coding Gene |
| Type: |
protein_coding_gene |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Protein Coding Gene |
| Type: |
protein_coding_gene |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Protein Coding Gene |
| Type: |
protein_coding_gene |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Protein Coding Gene |
| Type: |
protein_coding_gene |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Protein Coding Gene |
| Type: |
protein_coding_gene |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Protein Coding Gene |
| Type: |
protein_coding_gene |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Protein Coding Gene |
| Type: |
protein_coding_gene |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Protein Coding Gene |
| Type: |
protein_coding_gene |
| Organism: |
Mus pahari |
|
•
•
•
•
•
|
| Protein Coding Gene |
| Type: |
protein_coding_gene |
| Organism: |
Mus spretus |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Park CG |
| Year: |
1996 |
| Journal: |
Immunity |
| Title: |
A novel gene product that couples TCR signaling to Fas(CD95) expression in activation-induced cell death. |
| Volume: |
4 |
| Issue: |
6 |
| Pages: |
583-91 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Gomes I |
| Year: |
1999 |
| Journal: |
J Neurochem |
| Title: |
A proline- and glutamine-rich protein promotes apoptosis in neuronal cells. |
| Volume: |
73 |
| Issue: |
2 |
| Pages: |
612-22 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Rho J |
| Year: |
2001 |
| Journal: |
Mol Cell Biol |
| Title: |
TDAG51 is not essential for Fas/CD95 regulation and apoptosis in vivo. |
| Volume: |
21 |
| Issue: |
24 |
| Pages: |
8365-70 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Basseri S |
| Year: |
2013 |
| Journal: |
Diabetes |
| Title: |
Loss of TDAG51 results in mature-onset obesity, hepatic steatosis, and insulin resistance by regulating lipogenesis. |
| Volume: |
62 |
| Issue: |
1 |
| Pages: |
158-69 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Coleman SK |
| Year: |
2018 |
| Journal: |
Biochem Biophys Res Commun |
| Title: |
The Pleckstrin homology like domain family member, TDAG51, is temporally regulated during skeletal muscle regeneration. |
| Volume: |
495 |
| Issue: |
1 |
| Pages: |
499-505 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Platko K |
| Year: |
2020 |
| Journal: |
Arterioscler Thromb Vasc Biol |
| Title: |
TDAG51 (T-Cell Death-Associated Gene 51) Is a Key Modulator of Vascular Calcification and Osteogenic Transdifferentiation of Arterial Smooth Muscle Cells. |
| Volume: |
40 |
| Issue: |
7 |
| Pages: |
1664-1679 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Jeon H |
| Year: |
2022 |
| Journal: |
Sci Rep |
| Title: |
TDAG51 deficiency attenuates dextran sulfate sodium-induced colitis in mice. |
| Volume: |
12 |
| Issue: |
1 |
| Pages: |
20619 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Carlisle RE |
| Year: |
2012 |
| Journal: |
Am J Physiol Renal Physiol |
| Title: |
TDAG51 mediates epithelial-to-mesenchymal transition in human proximal tubular epithelium. |
| Volume: |
303 |
| Issue: |
3 |
| Pages: |
F467-81 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Yun H |
| Year: |
2019 |
| Journal: |
PLoS Genet |
| Title: |
TDAG51 is a crucial regulator of maternal care and depressive-like behavior after parturition. |
| Volume: |
15 |
| Issue: |
6 |
| Pages: |
e1008214 |
|
•
•
•
•
•
|
| GXD Expression |
| Probe: |
MGI:1342059 |
| Assay Type: |
Northern blot |
| Annotation Date: |
1999-08-18 |
| Strength: |
Present |
| Sex: |
Not Specified |
| Emaps: |
EMAPS:1603910 |
|
| Stage: |
TS10 |
| Assay Id: |
MGI:1342061 |
| Age: |
embryonic day 7.0 |
|
|
| Specimen Label: |
E7 |
| Detected: |
true |
| Specimen Num: |
1 |
|
•
•
•
•
•
|
| GXD Expression |
| Probe: |
MGI:1342059 |
| Assay Type: |
Northern blot |
| Annotation Date: |
1999-08-18 |
| Strength: |
Present |
| Sex: |
Not Specified |
| Emaps: |
EMAPS:1603918 |
|
| Stage: |
TS18 |
| Assay Id: |
MGI:1342061 |
| Age: |
embryonic day 11.0 |
|
|
| Specimen Label: |
E11 |
| Detected: |
true |
| Specimen Num: |
2 |
|
•
•
•
•
•
|
| GXD Expression |
| Probe: |
MGI:1342059 |
| Assay Type: |
Northern blot |
| Annotation Date: |
1999-08-18 |
| Strength: |
Present |
| Sex: |
Not Specified |
| Emaps: |
EMAPS:1603923 |
|
| Stage: |
TS23 |
| Assay Id: |
MGI:1342061 |
| Age: |
embryonic day 15.0 |
|
|
| Specimen Label: |
E15 |
| Detected: |
true |
| Specimen Num: |
3 |
|
•
•
•
•
•
|
| GXD Expression |
| Probe: |
MGI:1342059 |
| Assay Type: |
Northern blot |
| Annotation Date: |
1999-08-18 |
| Strength: |
Present |
| Sex: |
Not Specified |
| Emaps: |
EMAPS:1603925 |
|
| Stage: |
TS25 |
| Assay Id: |
MGI:1342061 |
| Age: |
embryonic day 17.0 |
|
|
| Specimen Label: |
E17 |
| Detected: |
true |
| Specimen Num: |
4 |
|
•
•
•
•
•
|
| GXD Expression |
| Probe: |
MGI:5473335 |
| Assay Type: |
Northern blot |
| Annotation Date: |
2013-04-08 |
| Strength: |
Not Specified |
| Sex: |
Male |
| Emaps: |
EMAPS:1797228 |
|
| Stage: |
TS28 |
| Assay Id: |
MGI:5473334 |
| Age: |
postnatal adult |
|
|
| Specimen Label: |
Te |
|
| Specimen Num: |
1 |
|
•
•
•
•
•
|
| GXD Expression |
| Probe: |
MGI:5473335 |
| Assay Type: |
Northern blot |
| Annotation Date: |
2013-04-08 |
| Strength: |
Not Specified |
| Sex: |
Not Specified |
| Emaps: |
EMAPS:1737328 |
|
| Stage: |
TS28 |
| Assay Id: |
MGI:5473334 |
| Age: |
postnatal adult |
|
|
| Specimen Label: |
Ki |
|
| Specimen Num: |
2 |
|
•
•
•
•
•
|
| GXD Expression |
| Probe: |
MGI:5473335 |
| Assay Type: |
Northern blot |
| Annotation Date: |
2013-04-08 |
| Strength: |
Absent |
| Sex: |
Not Specified |
| Emaps: |
EMAPS:3598828 |
|
| Stage: |
TS28 |
| Assay Id: |
MGI:5473334 |
| Age: |
postnatal adult |
|
|
| Specimen Label: |
Mu |
| Detected: |
false |
| Specimen Num: |
3 |
|
•
•
•
•
•
|
| GXD Expression |
| Probe: |
MGI:5473335 |
| Assay Type: |
Northern blot |
| Annotation Date: |
2013-04-08 |
| Strength: |
Present |
| Sex: |
Not Specified |
| Emaps: |
EMAPS:1684628 |
|
| Stage: |
TS28 |
| Assay Id: |
MGI:5473334 |
| Age: |
postnatal adult |
|
|
| Specimen Label: |
Li |
| Detected: |
true |
| Specimen Num: |
4 |
|
•
•
•
•
•
|
| GXD Expression |
| Probe: |
MGI:5473335 |
| Assay Type: |
Northern blot |
| Annotation Date: |
2013-04-08 |
| Strength: |
Present |
| Sex: |
Not Specified |
| Emaps: |
EMAPS:1672828 |
|
| Stage: |
TS28 |
| Assay Id: |
MGI:5473334 |
| Age: |
postnatal adult |
|
|
| Specimen Label: |
Lu |
| Detected: |
true |
| Specimen Num: |
5 |
|
•
•
•
•
•
|
| GXD Expression |
| Probe: |
MGI:5473335 |
| Assay Type: |
Northern blot |
| Annotation Date: |
2013-04-08 |
| Strength: |
Absent |
| Sex: |
Not Specified |
| Emaps: |
EMAPS:1876728 |
|
| Stage: |
TS28 |
| Assay Id: |
MGI:5473334 |
| Age: |
postnatal adult |
|
|
| Specimen Label: |
Sp |
| Detected: |
false |
| Specimen Num: |
6 |
|
•
•
•
•
•
|
| GXD Expression |
| Probe: |
MGI:5473335 |
| Assay Type: |
Northern blot |
| Annotation Date: |
2013-04-08 |
| Strength: |
Present |
| Sex: |
Not Specified |
| Emaps: |
EMAPS:1689428 |
|
| Stage: |
TS28 |
| Assay Id: |
MGI:5473334 |
| Age: |
postnatal adult |
|
|
| Specimen Label: |
Br |
| Detected: |
true |
| Specimen Num: |
7 |
|
•
•
•
•
•
|
| GXD Expression |
| Probe: |
MGI:5473335 |
| Assay Type: |
Northern blot |
| Annotation Date: |
2013-04-08 |
| Strength: |
Present |
| Sex: |
Not Specified |
| Emaps: |
EMAPS:1610528 |
|
| Stage: |
TS28 |
| Assay Id: |
MGI:5473334 |
| Age: |
postnatal adult |
|
|
| Specimen Label: |
He |
| Detected: |
true |
| Specimen Num: |
8 |
|
•
•
•
•
•
|
| GXD Expression |
| Probe: |
MGI:1056555 |
| Assay Type: |
RNA in situ |
| Annotation Date: |
2010-09-14 |
| Strength: |
Strong |
| Sex: |
Not Specified |
| Emaps: |
EMAPS:1804323 |
| Pattern: |
Regionally restricted |
| Stage: |
TS23 |
| Assay Id: |
MGI:4827190 |
| Age: |
embryonic day 14.5 |
| Image: |
euxassay_008411_14 |
|
| Specimen Label: |
euxassay_008411_14 |
| Detected: |
true |
| Specimen Num: |
14 |
|
•
•
•
•
•
|
| GXD Expression |
| Probe: |
MGI:1056555 |
| Assay Type: |
RNA in situ |
| Annotation Date: |
2010-09-14 |
| Strength: |
Strong |
| Sex: |
Not Specified |
| Emaps: |
EMAPS:1804323 |
| Pattern: |
Regionally restricted |
| Stage: |
TS23 |
| Assay Id: |
MGI:4827190 |
| Age: |
embryonic day 14.5 |
| Image: |
euxassay_008411_15 |
|
| Specimen Label: |
euxassay_008411_15 |
| Detected: |
true |
| Specimen Num: |
15 |
|
•
•
•
•
•
|
| GXD Expression |
| Probe: |
MGI:1056555 |
| Assay Type: |
RNA in situ |
| Annotation Date: |
2010-09-14 |
| Strength: |
Strong |
| Sex: |
Not Specified |
| Emaps: |
EMAPS:1804323 |
| Pattern: |
Regionally restricted |
| Stage: |
TS23 |
| Assay Id: |
MGI:4827190 |
| Age: |
embryonic day 14.5 |
| Image: |
euxassay_008411_16 |
|
| Specimen Label: |
euxassay_008411_16 |
| Detected: |
true |
| Specimen Num: |
16 |
|
•
•
•
•
•
|
| GXD Expression |
| Probe: |
MGI:1056555 |
| Assay Type: |
RNA in situ |
| Annotation Date: |
2010-09-14 |
| Strength: |
Strong |
| Sex: |
Not Specified |
| Emaps: |
EMAPS:1684323 |
| Pattern: |
Single cells |
| Stage: |
TS23 |
| Assay Id: |
MGI:4827190 |
| Age: |
embryonic day 14.5 |
| Image: |
euxassay_008411_06 |
|
| Specimen Label: |
euxassay_008411_06 |
| Detected: |
true |
| Specimen Num: |
6 |
|
•
•
•
•
•
|
| GXD Expression |
| Probe: |
MGI:1056555 |
| Assay Type: |
RNA in situ |
| Annotation Date: |
2010-09-14 |
| Strength: |
Moderate |
| Sex: |
Not Specified |
| Emaps: |
EMAPS:1716123 |
| Pattern: |
Regionally restricted |
| Stage: |
TS23 |
| Assay Id: |
MGI:4827190 |
| Age: |
embryonic day 14.5 |
| Image: |
euxassay_008411_03 |
|
| Specimen Label: |
euxassay_008411_03 |
| Detected: |
true |
| Specimen Num: |
3 |
|
•
•
•
•
•
|
| GXD Expression |
| Probe: |
MGI:1056555 |
| Assay Type: |
RNA in situ |
| Annotation Date: |
2010-09-14 |
| Strength: |
Strong |
| Sex: |
Not Specified |
| Emaps: |
EMAPS:1716123 |
| Pattern: |
Regionally restricted |
| Stage: |
TS23 |
| Assay Id: |
MGI:4827190 |
| Age: |
embryonic day 14.5 |
| Image: |
euxassay_008411_04 |
|
| Specimen Label: |
euxassay_008411_04 |
| Detected: |
true |
| Specimen Num: |
4 |
|
•
•
•
•
•
|
| GXD Expression |
| Probe: |
MGI:1056555 |
| Assay Type: |
RNA in situ |
| Annotation Date: |
2010-09-14 |
| Strength: |
Strong |
| Sex: |
Not Specified |
| Emaps: |
EMAPS:1716123 |
| Pattern: |
Regionally restricted |
| Stage: |
TS23 |
| Assay Id: |
MGI:4827190 |
| Age: |
embryonic day 14.5 |
| Image: |
euxassay_008411_05 |
|
| Specimen Label: |
euxassay_008411_05 |
| Detected: |
true |
| Specimen Num: |
5 |
|
•
•
•
•
•
|
| GXD Expression |
| Probe: |
MGI:1056555 |
| Assay Type: |
RNA in situ |
| Annotation Date: |
2010-09-14 |
| Strength: |
Strong |
| Sex: |
Not Specified |
| Emaps: |
EMAPS:1716123 |
| Pattern: |
Regionally restricted |
| Stage: |
TS23 |
| Assay Id: |
MGI:4827190 |
| Age: |
embryonic day 14.5 |
| Image: |
euxassay_008411_23 |
|
| Specimen Label: |
euxassay_008411_23 |
| Detected: |
true |
| Specimen Num: |
23 |
|
•
•
•
•
•
|
| GXD Expression |
| Probe: |
MGI:1056555 |
| Assay Type: |
RNA in situ |
| Annotation Date: |
2010-09-14 |
| Strength: |
Strong |
| Sex: |
Not Specified |
| Emaps: |
EMAPS:1716123 |
| Pattern: |
Regionally restricted |
| Stage: |
TS23 |
| Assay Id: |
MGI:4827190 |
| Age: |
embryonic day 14.5 |
| Image: |
euxassay_008411_24 |
|
| Specimen Label: |
euxassay_008411_24 |
| Detected: |
true |
| Specimen Num: |
24 |
|
•
•
•
•
•
|
| GXD Expression |
| Probe: |
MGI:1056555 |
| Assay Type: |
RNA in situ |
| Annotation Date: |
2010-09-14 |
| Strength: |
Strong |
| Sex: |
Not Specified |
| Emaps: |
EMAPS:1756423 |
| Pattern: |
Regionally restricted |
| Stage: |
TS23 |
| Assay Id: |
MGI:4827190 |
| Age: |
embryonic day 14.5 |
| Image: |
euxassay_008411_05 |
|
| Specimen Label: |
euxassay_008411_05 |
| Detected: |
true |
| Specimen Num: |
5 |
|
•
•
•
•
•
|
| GXD Expression |
| Probe: |
MGI:1056555 |
| Assay Type: |
RNA in situ |
| Annotation Date: |
2010-09-14 |
| Strength: |
Strong |
| Sex: |
Not Specified |
| Emaps: |
EMAPS:1756423 |
| Pattern: |
Regionally restricted |
| Stage: |
TS23 |
| Assay Id: |
MGI:4827190 |
| Age: |
embryonic day 14.5 |
| Image: |
euxassay_008411_06 |
|
| Specimen Label: |
euxassay_008411_06 |
| Detected: |
true |
| Specimen Num: |
6 |
|
•
•
•
•
•
|
| GXD Expression |
| Probe: |
MGI:1056555 |
| Assay Type: |
RNA in situ |
| Annotation Date: |
2010-09-14 |
| Strength: |
Strong |
| Sex: |
Not Specified |
| Emaps: |
EMAPS:1756423 |
| Pattern: |
Regionally restricted |
| Stage: |
TS23 |
| Assay Id: |
MGI:4827190 |
| Age: |
embryonic day 14.5 |
| Image: |
euxassay_008411_07 |
|
| Specimen Label: |
euxassay_008411_07 |
| Detected: |
true |
| Specimen Num: |
7 |
|
•
•
•
•
•
|
| GXD Expression |
| Probe: |
MGI:1056555 |
| Assay Type: |
RNA in situ |
| Annotation Date: |
2010-09-14 |
| Strength: |
Strong |
| Sex: |
Not Specified |
| Emaps: |
EMAPS:1756423 |
| Pattern: |
Regionally restricted |
| Stage: |
TS23 |
| Assay Id: |
MGI:4827190 |
| Age: |
embryonic day 14.5 |
| Image: |
euxassay_008411_08 |
|
| Specimen Label: |
euxassay_008411_08 |
| Detected: |
true |
| Specimen Num: |
8 |
|
•
•
•
•
•
|
| GXD Expression |
| Probe: |
MGI:1056555 |
| Assay Type: |
RNA in situ |
| Annotation Date: |
2010-09-14 |
| Strength: |
Strong |
| Sex: |
Not Specified |
| Emaps: |
EMAPS:1756423 |
| Pattern: |
Regionally restricted |
| Stage: |
TS23 |
| Assay Id: |
MGI:4827190 |
| Age: |
embryonic day 14.5 |
| Image: |
euxassay_008411_09 |
|
| Specimen Label: |
euxassay_008411_09 |
| Detected: |
true |
| Specimen Num: |
9 |
|
•
•
•
•
•
|
| GXD Expression |
| Probe: |
MGI:1056555 |
| Assay Type: |
RNA in situ |
| Annotation Date: |
2010-09-14 |
| Strength: |
Strong |
| Sex: |
Not Specified |
| Emaps: |
EMAPS:1756423 |
| Pattern: |
Regionally restricted |
| Stage: |
TS23 |
| Assay Id: |
MGI:4827190 |
| Age: |
embryonic day 14.5 |
| Image: |
euxassay_008411_10 |
|
| Specimen Label: |
euxassay_008411_10 |
| Detected: |
true |
| Specimen Num: |
10 |
|
•
•
•
•
•
|
| GXD Expression |
| Probe: |
MGI:1056555 |
| Assay Type: |
RNA in situ |
| Annotation Date: |
2010-09-14 |
| Strength: |
Strong |
| Sex: |
Not Specified |
| Emaps: |
EMAPS:1756423 |
| Pattern: |
Regionally restricted |
| Stage: |
TS23 |
| Assay Id: |
MGI:4827190 |
| Age: |
embryonic day 14.5 |
| Image: |
euxassay_008411_11 |
|
| Specimen Label: |
euxassay_008411_11 |
| Detected: |
true |
| Specimen Num: |
11 |
|
•
•
•
•
•
|
| GXD Expression |
| Probe: |
MGI:1056555 |
| Assay Type: |
RNA in situ |
| Annotation Date: |
2010-09-14 |
| Strength: |
Strong |
| Sex: |
Not Specified |
| Emaps: |
EMAPS:1756423 |
| Pattern: |
Regionally restricted |
| Stage: |
TS23 |
| Assay Id: |
MGI:4827190 |
| Age: |
embryonic day 14.5 |
| Image: |
euxassay_008411_12 |
|
| Specimen Label: |
euxassay_008411_12 |
| Detected: |
true |
| Specimen Num: |
12 |
|
•
•
•
•
•
|
| GXD Expression |
| Probe: |
MGI:1056555 |
| Assay Type: |
RNA in situ |
| Annotation Date: |
2010-09-14 |
| Strength: |
Strong |
| Sex: |
Not Specified |
| Emaps: |
EMAPS:1756423 |
| Pattern: |
Regionally restricted |
| Stage: |
TS23 |
| Assay Id: |
MGI:4827190 |
| Age: |
embryonic day 14.5 |
| Image: |
euxassay_008411_13 |
|
| Specimen Label: |
euxassay_008411_13 |
| Detected: |
true |
| Specimen Num: |
13 |
|
•
•
•
•
•
|
| GXD Expression |
| Probe: |
MGI:1056555 |
| Assay Type: |
RNA in situ |
| Annotation Date: |
2010-09-14 |
| Strength: |
Strong |
| Sex: |
Not Specified |
| Emaps: |
EMAPS:1756423 |
| Pattern: |
Regionally restricted |
| Stage: |
TS23 |
| Assay Id: |
MGI:4827190 |
| Age: |
embryonic day 14.5 |
| Image: |
euxassay_008411_14 |
|
| Specimen Label: |
euxassay_008411_14 |
| Detected: |
true |
| Specimen Num: |
14 |
|
•
•
•
•
•
|
| GXD Expression |
| Probe: |
MGI:1056555 |
| Assay Type: |
RNA in situ |
| Annotation Date: |
2010-09-14 |
| Strength: |
Strong |
| Sex: |
Not Specified |
| Emaps: |
EMAPS:1756423 |
| Pattern: |
Regionally restricted |
| Stage: |
TS23 |
| Assay Id: |
MGI:4827190 |
| Age: |
embryonic day 14.5 |
| Image: |
euxassay_008411_15 |
|
| Specimen Label: |
euxassay_008411_15 |
| Detected: |
true |
| Specimen Num: |
15 |
|
•
•
•
•
•
|